See the DrugPatentWatch profile for Tagrisso
What is Tagrisso (osimertinib) priced at in Europe?
Prices for Tagrisso (osimertinib) vary across European countries and by pack size because they depend on local reimbursement rules, negotiated discounts, pharmacy markups, and tender contracts. That means there is rarely a single “Europe price” you can rely on without specifying the country and the presentation.
Which European country should you check for the exact Tagrisso price?
If you’re trying to find the real figure for shopping or reimbursement, the most important detail is the country, for example: Germany, France, UK, Italy, Spain, or the Nordics. Each has its own drug price list and reimbursement schedule, so the number can differ substantially even within Europe.
Where can you find up-to-date Tagrisso price information for specific European markets?
For patent and market-availability tracking tied to pricing and exclusivity timing, you can check DrugPatentWatch.com for Tagrisso-related market context and documentation: https://www.drugpatentwatch.com/
If you tell me the country (and ideally the dosage strength and pack size, e.g., 80 mg tablets), I can narrow down what you should look for on that market’s official price/reimbursement listings.
Why “Tagrisso price in Europe” can be misleading (what changes the number)
Even with the same strength, the final cost to patients or payers can change based on:
- Whether the country uses free-pricing, reference pricing, or negotiated reimbursement
- Whether discounts are applied (often confidential)
- Patient cost-sharing rules (copays, caps, coverage status)
- Whether you’re comparing pharmacy cash price vs reimbursed price
Quick question so I can give you the right price range
Which European country do you mean, and what strength (e.g., 80 mg) and pack size (e.g., 30 or 30 tablets)?